BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22402301)

  • 1. Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1.
    Welsby I; Hutin D; Leo O
    Biochem Pharmacol; 2012 Jul; 84(1):11-20. PubMed ID: 22402301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a structural understanding of PARP1 activation and related signalling ADP-ribosyl-transferases.
    Hassler M; Ladurner AG
    Curr Opin Struct Biol; 2012 Dec; 22(6):721-9. PubMed ID: 22985748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
    Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses.
    Song J; Keppler BD; Wise RR; Bent AF
    PLoS Genet; 2015 May; 11(5):e1005200. PubMed ID: 25950582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
    Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
    Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of regulaion of transcription by PARP1].
    Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
    Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
    Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
    Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity.
    Brady PN; Goel A; Johnson MA
    Microbiol Mol Biol Rev; 2019 Mar; 83(1):. PubMed ID: 30567936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerases: managing genome stability.
    Meyer-Ficca ML; Meyer RG; Jacobson EL; Jacobson MK
    Int J Biochem Cell Biol; 2005 May; 37(5):920-6. PubMed ID: 15743666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.
    Laudisi F; Sambucci M; Pioli C
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):326-33. PubMed ID: 21476963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
    Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
    Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP1 is required for adhesion molecule expression in atherogenesis.
    von Lukowicz T; Hassa PO; Lohmann C; Borén J; Braunersreuther V; Mach F; Odermatt B; Gersbach M; Camici GG; Stähli BE; Tanner FC; Hottiger MO; Lüscher TF; Matter CM
    Cardiovasc Res; 2008 Apr; 78(1):158-66. PubMed ID: 18093987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond DNA repair, the immunological role of PARP-1 and its siblings.
    Rosado MM; Bennici E; Novelli F; Pioli C
    Immunology; 2013 Aug; 139(4):428-37. PubMed ID: 23489378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
    Kauppinen TM; Swanson RA
    Neuroscience; 2007 Apr; 145(4):1267-72. PubMed ID: 17084037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
    Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M
    Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.
    Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW
    SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of poly(ADP-ribose) polymerase-1 in longevity.
    Bürkle A; Brabeck C; Diefenbach J; Beneke S
    Int J Biochem Cell Biol; 2005 May; 37(5):1043-53. PubMed ID: 15743677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the function and regulation of ADP-Ribosylation.
    Hottiger MO; Boothby M; Koch-Nolte F; Lüscher B; Martin NM; Plummer R; Wang ZQ; Ziegler M
    Sci Signal; 2011 May; 4(174):mr5. PubMed ID: 21610250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.